Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Return on Assets: 2020-2023

Historic Return on Assets for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to -0.32%.

  • ADC Therapeutics' Return on Assets fell 5.00% to -0.32% in Q3 2023 from the same period last year, while for Sep 2023 it was -0.32%, marking a year-over-year decrease of 5.00%. This contributed to the annual value of -0.00% for FY2022, which is N/A change from last year.
  • As of Q3 2023, ADC Therapeutics' Return on Assets stood at -0.32%, which was up 4.12% from -0.33% recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Return on Assets ranged from a high of -0.26% in Q3 2022 and a low of -424.39% during Q3 2020.
  • In the last 3 years, ADC Therapeutics' Return on Assets had a median value of -0.37% in 2023 and averaged -0.46%.
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 42,400bps in 2021, then decreased by 5bps in 2023.
  • ADC Therapeutics' Return on Assets (Quarterly) stood at -424.39% in 2020, then skyrocketed by 42,400bps to -0.61% in 2021, then soared by 34bps to -0.27% in 2022, then decreased by 5bps to -0.32% in 2023.
  • Its Return on Assets was -0.32% in Q3 2023, compared to -0.33% in Q2 2023 and -0.37% in Q1 2023.